Ashland Inc.

Ashland Inc.

ASH
Ashland Inc.US flagNew York Stock Exchange
65.34
USD
+0.36
- -
2.99BMarket Cap
Ashland Inc.
ASH
(New York Stock Exchange)

Recent

price

65.34

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
72.67
83.36
81.92
79.1
87.44
51.04
48.69
37.24
41.76
35.8
33.05
37.04
44.28
42.96
44.96
39.65
39.46
Revenue per Share
1.78
5.31
0.33
8.87
3.33
4.61
-0.47
0.02
1.84
8.42
-8.33
3.86
17.17
3.49
3.6
-18.37
-15.41
Basic EPS, GAAP
3.97
0.56
1.42
6.09
5.64
1.69
7.21
3.47
2.26
1.57
1.15
7.98
-6.04
1.43
5.83
-0.09
4.32
Free Cash Flow per Basic Share
0.44
0.65
0.8
1.14
1.47
1.46
1.56
1.24
0.97
1.07
1.08
1.23
1.3
1.49
1.66
1.65
1.66
Dividend per Share
44.09
41.04
40.05
48.82
49.66
48.99
43.63
43.5
44.37
53.75
43.44
49.07
67.67
70.51
70.55
49.98
49.7
Book Value per Share
5.85
-16.99
-16.28
4.84
-5.6
-9.15
-0.89
-6.35
-1.52
3.73
11.7
3.79
17.39
16.53
15.53
13.72
13.9
Tangible Book Value per Share
79
78
79
77
70
67
62
62
62
60
61
57
54
51
47
46
46
Basic Weighted Avg Shares
5,741
6,502
6,472
6,091
6,121
3,420
3,019
2,309
2,589
2,148
2,016
2,111
2,391
2,191
2,113
1,824
1,808
Sales/Revenue/Turnover
3.5
1.25
3.52
16.01
0.72
2.84
-1.92
2.12
3.94
3.82
2.93
8.15
12.05
7.26
3.93
4.82
4.54
Operating Margin (%)
280
299
359
356
393
306
302
265
277
277
235
244
241
243
274
237
219
Depreciation Expense
141
414
26
683
233
309
-29
1
114
505
-508
220
927
178
169
-845
-706
Net Income, GAAP
- -
- -
- -
26.17
- -
- -
- -
- -
- -
- -
- -
- -
12.14
- -
- -
- -
74.23
Effective Tax Rate (%)
2.46
6.37
0.4
11.21
3.81
9.04
-0.96
0.04
4.4
23.51
-25.2
10.42
38.77
8.12
8
-46.33
-39.05
Profit Margin (%)
1,146
1,648
1,296
1,146
1,874
1,651
1,650
935
636
676
734
783
1,215
1,050
705
782
814
Working Capital
1,108
3,648
3,131
2,947
2,911
3,348
2,325
2,584
2,275
1,501
1,687
1,706
1,364
1,420
1,448
1,469
1,459
LT Debt
3,803
4,135
4,029
4,553
3,583
3,037
3,165
3,406
3,406
3,571
3,036
2,752
3,220
3,097
2,868
1,904
1,866
Total Equity
- -
- -
- -
9.34
- -
- -
- -
- -
- -
- -
- -
- -
5.35
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
12.84
- -
- -
- -
- -
- -
- -
- -
- -
19.75
- -
- -
- -
-17.28
Return on Capital (%)
4.23
12.39
0.82
19.73
6.44
9.14
-0.97
0.04
4.19
16.9
-17.29
8.08
28.74
4.91
4.89
-30.1
-26.51
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Sep'25
Dec'26
Mar'26
ST Debt
21
19
19
LT Borrowings
1,384
1,387
1,374
LT Finance Leases
85
83
85
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
46
46
46
Market Capitalization
2,211
2,687
2,548

Working Capital

FRC

in mil. unless spec.
Sep'25
Dec'26
Mar'26
Total Current Assets
1,205
1,154
1,209
Cash, Cash Equivalents & STI
215
304
343
Accounts Receivable, Net
242
190
244
Inventories
568
565
506
Total Current Liabilities
423
366
395
Payables & Accruals
402
347
376
ST Debt
21
19
19
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-7.43%
-33.61%
Free Cash Flow
58.02%
85.97%
-101.46%
Net Income, GAAP
1,072.17%
-101.56%
-600%
Sales/Revenue/Turnover
-5.39%
-1.53%
-13.68%
Total Cash Common Dividend
- -
- -
-2.56%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
473
575
544
522
2,113
2025
405
479
463
477
1,824
2026
386
482
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.52
2.39
0.12
0.34
3.6
2025
-3.5
0.68
-16.23
0.7
-18.37
2026
-0.26
0.35
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.4
0.38
0.41
0.4
1.66
2025
0.4
0.42
0.42
0.41
1.65
2026
0.42
0.41
- -
- -
- -
Business
Ashland Inc. operates as a global additives and specialty ingredients company serving consumer and industrial markets. The company manufactures and supplies a diverse portfolio of products, including specialty additives for architectural coatings, construction, energy, and automotive markets; life sciences products such as pharmaceuticals, nutrition, agricultural chemicals, and diagnostic films; personal care offerings encompassing biofunctionals, microbial protectants, skin care, sun care, oral care, and hair care solutions; and intermediates such as 1,4-butanediol (BDO) and related chemical derivatives. Ashland's Specialty Ingredients segment provides cellulose ethers, vinyl pyrrolidones, biofunctionals, and various polymers used in adhesives, coatings, pharmaceuticals, textiles, food and beverages, and nutraceuticals. Its consumer specialties division delivers products for oral care, hair care, skin care, and home care, while its industrial specialties serve packaging, automotive, and industrial applications. Founded in 2004 and headquartered in Wilmington, Delaware, Ashland operates across North America, Latin America, Europe, and Asia Pacific, with about 3,000 employees. The company focuses on higher-margin, resilient end markets through portfolio refinement and divestitures to streamline operations. Recently, Ashland completed the sale of its Avoca business in March 2025, aligning with its strategy to prioritize core specialty ingredients businesses. The company is pursuing restructuring and manufacturing optimization initiatives, including consolidating manufacturing operations and improving process productivity. Innovation is a key growth driver, with an ambitious plan to launch seven new products in 2025, targeting incremental sales growth through new and improved specialty ingredients, particularly in life sciences and personal care. Ashland reported double-digit growth in personal care sales driven by strong demand in skin and hair care sectors while managing challenges from customer destocking and structural market changes, especially in China. The company maintains a strong liquidity position with $300 million in cash and a total liquidity of $896 million as of late 2024. Its strategic focus includes expanding high-growth, sustainable, and biologics-related specialty ingredients, aiming to enhance profitability and generate significant sales improvements by 2027 through continuous innovation and operational efficiency enhancements. Ashland's long-term strategy emphasizes profitable growth via innovation, portfolio optimization, and manufacturing excellence to support its global footprint and diverse market presence.

Company News

MCPAPIChat
  • Ashland responds to investor presentation by Ancora Alternatives LLC

  • Ashland responds to investor presentation by Ancora Alternatives LLC

  • New Strong Sell Stocks for June 10th

  • Ancora Releases Presentation Highlighting the Opportunity for a Value-Maximizing, Competitive Sale Process at Ashland Inc.

  • New Strong Sell Stocks for June 8th

  • Dividend Champion, Contender, And Challenger Highlights: Week Of June 7

  • Why Is Ashland (ASH) Up 16.6% Since Last Earnings Report?

  • New Strong Sell Stocks for May 28th

  • New Strong Sell Stocks for May 22nd

  • INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ashland Inc. - ASH

  • INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ashland Inc. - ASH

  • Ashland Board appoints Bertrand Loy as new director

  • INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ashland Inc. - ASH

  • INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ashland Inc. - ASH

  • ASH Investors Have Opportunity to Join Ashland Inc. Fraud Investigation with the Schall Law Firm

  • New Strong Sell Stocks for May 13th

  • INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ashland Inc. - ASH

  • INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ashland Inc. - ASH

  • Ashland board authorizes quarterly dividend

  • ASH Q2 Earnings and Sales Miss on Weak Pricing, Intermediates Weakness